Turning viruses
into anti-cancer molecular weapons
Our Mission
Guska's mission is to develop innovative oncolytic
virus-based cancer therapies that improve the quality of
life for patients suffering from some of the most
devastating forms of cancer.
virus-based cancer therapies that improve the quality of
life for patients suffering from some of the most
devastating forms of cancer.
Designing viruses
to fight cancer




Solution
Guska is developing synthetic RNA oncolytic virus therapy
that delivers powerful and safe immunostimulatory effects.
Our approach targets cancer directly, providing a more
effective and less harmful alternative. By addressing the key challenges of cancer
therapy, we aim to offer patients a promising solution that
minimizes side effects while maximizing treatment efficacy.
Our Approach
In Guska, we developed synthetic RNA oncolytic virus therapies designed to deliver potent and safe immunostimulatory effects. By precisely targeting and eliminating cancer cells while preserving healthy tissue, our innovative approach offers a more effective and less harmful alternative to traditional treatments. Beyond direct cancer targeting, our therapies stimulate a robust immune response, empowering the body to fight tumors more effectively and paving the way for improved patient outcomes.

“
Our Vision
Lorem ipsum dolor sit amet consectetur adipiscing elit
iaculis montes massa ultricies eleifend feugiat, eget vitae
leo ornare interdum malesuada fringilla blandit senectus
suspendisse volutpat. Sollicitudin facilisis nascetur fusce
sodales class mi nec mattis habitasse
Our Team
Members
Great things Happen when
we work together.
we work together.